Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.6B |
| 2 |
Broadcom
AVGO
|
+$1.11B |
| 3 |
Invesco QQQ Trust
QQQ
|
+$882M |
| 4 |
JPMorgan Chase
JPM
|
+$628M |
| 5 |
Tesla
TSLA
|
+$594M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Honeywell
HON
|
+$1.54B |
| 2 |
Visa
V
|
+$1.39B |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.13B |
| 4 |
Amazon
AMZN
|
+$771M |
| 5 |
Berkshire Hathaway Class B
BRK.B
|
+$575M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.83% |
| 2 | Financials | 7.37% |
| 3 | Consumer Discretionary | 6.6% |
| 4 | Communication Services | 5.05% |
| 5 | Healthcare | 4.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3401
Amylyx Pharmaceuticals
AMLX
$2.6B
| $835K | ﹤0.01% |
130,274
-7,131
| -5% | -$34.7K |
|
3402
Liberty Latin America Class A
LILA
$1.69B
| $834K | ﹤0.01% |
201,243
+109,322
| +119% | +$396K |
|
3403
Wabash National
WNC
$507M
| $832K | ﹤0.01% |
78,264
-31,003
| -28% | -$298K |
|
|
NUTX
3404
Nutex Health
NUTX
$1.18B
| $831K | ﹤0.01% |
+6,678
| New | +$863K |
|
|
FSUN
3405
FirstSun Capital Bancorp
FSUN
$2.01B
| $831K | ﹤0.01% |
23,914
+13,497
| +130% | +$473K |
|
3406
Klaviyo
KVYO
$5.47B
| $828K | ﹤0.01% |
24,657
-7,915
| -24% | -$251K |
|
3407
CALL
L3Harris
LHX
$54.1B
| $828K | ﹤0.01% |
+3,300
| New | +$758K |
|
|
EHAB
3408
DELISTED
Enhabit
EHAB
| $827K | ﹤0.01% |
85,744
+32,202
| +60% | +$297K |
|
3409
JELD-WEN Holding
JELD
$164M
| $826K | ﹤0.01% |
210,688
+53,258
| +34% | +$237K |
|
|
NUVL
3410
CALL
DELISTED
Nuvalent
NUVL
| $824K | ﹤0.01% |
+10,800
| New | +$790K |
|
3411
Ardmore Shipping
ASC
$681M
| $821K | ﹤0.01% |
85,503
+35,053
| +69% | +$338K |
|
3412
Toyota
TM
$223B
| $820K | ﹤0.01% |
4,763
+1,884
| +65% | +$341K |
|
3413
Zumiez
ZUMZ
$318M
| $820K | ﹤0.01% |
61,863
+17,314
| +39% | +$219K |
|
3414
Bank7 Corp
BSVN
$495M
| $820K | ﹤0.01% |
19,604
+5,579
| +40% | +$212K |
|
|
BRY
3415
DELISTED
Berry Corp
BRY
| $820K | ﹤0.01% |
296,024
+75,033
| +34% | +$200K |
|
3416
EVgo
EVGO
$497M
| $819K | ﹤0.01% |
224,401
+62,277
| +38% | +$213K |
|
|
OLP
3417
One Liberty Properties
OLP
$523M
| $816K | ﹤0.01% |
34,211
+14,705
| +75% | +$359K |
|
|
NLOP
3418
Net Lease Office Properties
NLOP
$171M
| $815K | ﹤0.01% |
25,024
+9,633
| +63% | +$295K |
|
3419
United States Antimony
UAMY
$744M
| $809K | ﹤0.01% |
+371,214
| New | +$1.05M |
|
|
RAPP
3420
Rapport Therapeutics
RAPP
$2.29B
| $808K | ﹤0.01% |
71,108
+8,412
| +13% | +$89.3K |
|
3421
America's Car Mart
CRMT
$26.2M
| $808K | ﹤0.01% |
14,427
-12,282
| -46% | -$608K |
|
3422
CALL
CRH
CRH
$65.2B
| $808K | ﹤0.01% |
8,800
+800
| +10% | +$73K |
|
|
SLSN
3423
Solesence Inc
SLSN
$74.2M
| $807K | ﹤0.01% |
+185,148
| New | +$650K |
|
3424
Preformed Line Products
PLPC
$2.29B
| $806K | ﹤0.01% |
5,045
+2,048
| +68% | +$292K |
|
|
SRTA
3425
Strata Critical Medical Inc
SRTA
$533M
| $804K | ﹤0.01% |
199,458
+47,981
| +32% | +$156K |
|
Similar funds
Barclays's Q2 2025 Portfolio in Review
As of Q2 2025, Barclays held 5,681 positions worth $436B, up 24% from $353B the previous quarter. Its ten largest holdings account for 43% of the portfolio.
Barclays deployed $35.4B of net new capital in Q2 2025, opening 461 new positions and adding to 2,914 existing holdings. Its largest new stake was iShares MBS ETF: 4,310,047 shares worth $405M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 18% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was Honeywell, an estimated $1.54B trimmed.
- Barclays's largest Q2 2025 buy was iShares MBS ETF: 4,310,047 shares worth $405M.
- Barclays added most to NVIDIA in Q2 2025, an estimated $1.6B increase.
- Barclays's biggest Q2 2025 reduction was Honeywell, cutting an estimated $1.54B.
- Barclays fully exited Berry Global Group, Inc. in Q2 2025, selling an estimated $173M.
- Barclays's ten largest holdings make up 43% of its $436B portfolio in Q2 2025.
- Barclays opened 461 new positions and closed 463 in Q2 2025.
- Barclays's portfolio value rose 24% quarter-over-quarter to $436B.
Based on Barclays's 13F filing for Q2 2025, filed 13 Aug 2025.